U.S. appellate judges seem divided on gene editing patents decision

(Reuters) - U.S. appeals court judges appear divided over whether to allow a research center affiliated with MIT and Harvard to keep patents potentially worth billions of dollars on a groundbreaking gene editing technology known as CRISPR.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news